Quick Answer
Regenerative Medical Technology Group Inc. reported Total Revenue of $4.11 million for fiscal year 2024.
Regenerative Medical Technology Group Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $4.11M | +70.4% |
| 2023 | $2.41M | +57.5% |
| 2022 | $1.53M | +249.5% |
| 2021 | $437.9K | +695.0% |
| 2020 | $55.1K | +83.0% |
| 2019 | $30.1K | -39.9% |
| 2018 | $50.1K | +71.4% |
| 2017 | $29.2K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.18M | +19.7% | +20.0% |
| June 30, 2025 | $983.5K | +24.0% | -27.9% |
| March 31, 2025 | $1.36M | +67.0% | +38.3% |
| September 30, 2024 | $986.3K | +52.5% | +24.3% |
| June 30, 2024 | $793.3K | +119.5% | -2.9% |
| March 31, 2024 | $817.0K | +3.9% | +26.3% |
| September 30, 2023 | $646.8K | +75.9% | +79.0% |
| June 30, 2023 | $361.4K | +21.5% | -54.0% |
- Regenerative Medical Technology Group Inc. showed an increase of +70.4% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2024 period, Regenerative Medical Technology Group Inc.’s total revenue has grown by 13947.0% (from $29.2 thousand to $4.11 million).
- The most recent figure is from Regenerative Medical Technology Group Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: